Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT02741323

Public ClinicalTrials.gov record NCT02741323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02741323
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
97 participants

Conditions and interventions

Interventions

  • Maraviroc Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2016
Primary completion
May 9, 2022
Completion
May 9, 2022
Last update posted
Aug 20, 2023

2017 – 2022

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
UAB HIVTR-CCR5 Non-Network CRS Birmingham Alabama 35233-2060
UCLA HIVTR-CCR5 Non-Network CRS Los Angeles California 90024
UCSF HIVTR-CCR5 Non-network CRS San Francisco California 94118
Georgetown HIVTR-CCR5 Non-Network CRS Washington D.C. District of Columbia 20007
Emory HIVTR-CCR5 Non-Network CRS Atlanta Georgia 30322
Northwestern HIVTR-CCR5 Non-Network CRS Chicago Illinois 60611-2927
Univ. of Maryland HIVTR-CCR5 Non-Network CRS Baltimore Maryland 21201
JHU HIVTR-CCR5 Non-Network CRS Baltimore Maryland 21287
Mt. Sinai Med. Ctr. HIVTR-CCR5 Non-Network CRS New York New York 10029
Univ. of Penn HIVTR-CCR5 Non-network CRS Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02741323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2023 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02741323 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →